Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial
NCT03462511
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL:
HABIT Intervention
OTHER:
Standard of Care
OTHER:
Education materials
Sponsor
Columbia University
Collaborators
[object Object]